WHO types A and AB thymomas: Not always benign

Modern Pathology

Volumn 23, Issue 12, 2010, Pages 1641-1649

  Jain, Rohit K ^a   Mehta, Rutika J ^a   Henley, John D ^b   Kesler, Kenneth A ^a   Loehrer, Patrick J ^a,c   Badve, Sunil ^a,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Pain Center   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

thymoma; type A; type AB; WHO

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; THYMOMA; TUMOR RECURRENCE; WORLD HEALTH ORGANIZATION;

EID: 78649715497     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.172     Document Type: Article

References (54)

1. Levine GD, Rosai J. Thymic hyperplasia and neoplasia: a review of current concepts. Hum Pathol 1978;9: 495-515.
2. Lattes R. Thymoma and other tumors of the thymus. An analysis of 107 cases. Cancer 1962;15:1224-1260.
3. Muller-Hermelink HK, Marino M, Palestro G, et al. Immunohistological evidences of cortical and medullary differentiation in thymoma. Virchows Arch A Pathol Anat Histopathol 1985;408:143-161.
4. Kirchner T, Muller-Hermelink HK. New approaches to the diagnosis of thymic epithelial tumors. Prog Surg Pathol 1989;10:167-189.
5. Rosai J. Histological Typing of Tumors of the Thymus 2nd edn, Vol. Springer-Verlag: Berlin, Germany, 1999.
6. Travis WD, Brambilla E, Muller-Hermelink HK, et al. Pathology and Genetics of the Lung, Pleura, Thymus and Heart, Vol., IARC Press: Lyon, France, 2004.
7. Suster S, Moran CA. Problem areas and inconsistencies in the WHO classification of thymoma. Semin Diagn Pathol 2005;22:188-197.
8. Detterbeck FC. Clinical value of the WHO classification system of thymoma. Ann Thorac Surg 2006; 81:2328-2334.
9. Suster S, Moran CA. Histologic classification of thymoma: the World Health Organization and beyond. Hematol Oncol Clin North Am 2008;22:381-392.
10. Masaoka A, Monden Y, Nakahara K, et al. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981;48:2485-2492.
11. Wright CD, Wain JC, Wong DR, et al. Predictors of recurrence in thymic tumors: importance of invasion, World Health Organization histology, and size. J Thorac Cardiovasc Surg 2005;130:1413-1421.
12. Pan CC, Chen WY, Chiang H. Spindle cell and mixed spindle/lymphocytic thymomas: an integrated clinico-pathologic and immunohistochemical study of 81 cases. Am J Surg Pathol 2001;25:111-120.
13. Venuta F, Rendina EA, Pescarmona EO, et al. Multimodality treatment of thymoma: a prospective study. Ann Thorac Surg 1997;64:1585-1591, discussion 91-2.
14. Harris NL, Muller-Hermelink HK. Thymoma classification. A siren's song of simplicity. Am J Clin Pathol 1999;112:299-303.
15. Marx A, Muller-Hermelink HK. Thymoma and thymic carcinoma. Am J Surg Pathol 1999;23:739-742.
16. Muller-Hermelink HK, Marx A. Thymoma. Curr Opin Oncol 2000;12:426-433.
17. Blumberg D, Port JL, Weksler B, et al. Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg 1995;60:908-913, discussion 14.
18. Chahinian AP, Bhardwaj S, Meyer RJ, et al. Treatment of invasive or metastatic thymoma: report of eleven cases. Cancer 1981;47:1752-1761.
19. Chalabreysse L, Roy P, Cordier JF, et al. Correlation of the WHO schema for the classification of thymic epithelial neoplasms with prognosis: a retrospective study of 90 tumors. Am J Surg Pathol 2002;26: 1605-1611.
20. Ciernik IF, Meier U, Lutolf UM. Prognostic factors and outcome of incompletely resected invasive thymoma following radiation therapy. J Clin Oncol 1994;12: 1484-1490.
21. Gamboa EO, Sawhney V, Lanoy RS, et al. Widespread metastases after resection of noninvasive thymoma. J Clin Oncol 2008;26:1752-1755.
22. Huang J, Rizk NP, Travis WD, et al. Comparison of patterns of relapse in thymic carcinoma and thymoma. J Thorac Cardiovasc Surg 2009;138:26-31.
23. Ibrahim NB, Briggs JC, Jeyasingham K, et al. Metasta-sising thymoma. Thorax 1982;37:771-773.
24. Koga K, Matsuno Y, Noguchi M, et al. A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int 1994;44:359-367.
25. LeGolvan DP, Abell MR. Thymomas. Cancer 1977; 39:2142-2157.
26. Lewis JE, Wick MR, Scheithauer BW, et al. Thymoma. A clinicopathologic review. Cancer 1987; 60:2727-2743.
27. Monden Y, Nakahara K, Iioka S, et al. Recurrence of thymoma: clinicopathological features, therapy, and prognosis. Ann Thorac Surg 1985;39:165-169.
28. Naniwa T, Kakihara H, Zen-nami S, et al. [Recurrence of thymoma accompanied with hypogammaglobuline-mia 20 years after surgery: a case report]. Nihon Kokyuki Gakkai Zasshi 2002;40:241-244.
29. Regnard JF, Magdeleinat P, Dromer C, et al. Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg 1996;112:376-384.
30. Rena O, Papalia E, Maggi G, et al. World Health Organization histologic classification: an independent prognostic factor in resected thymomas. Lung Cancer 2005;50:59-66.
31. Singhal S, Shrager JB, Rosenthal DI, et al. Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation. Ann Thorac Surg 2003;76:1635-1641, discussion 41-2.
32. Tan PH, Sng IT. Thymoma- a study of 60 cases in Singapore. Histopathology 1995;26:509-518.
33. Verley JM, Hollmann KH. Thymoma. A comparative study of clinical stages, histologic features, and survival in 200 cases. Cancer 1985;55:1074-1086.
34. Wang LS, Huang MH, Lin TS, et al. Malignant thymoma. Cancer 1992;70:443-450.
35. Okumura M, Ohta M, Tateyama H, et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 2002;94:624-632.
36. Guillan RA, Zelman S, Smalley RL, et al. Malignant thymoma associated with myasthenia gravis, and evidence of extrathoracic metastases. An analysis of published cases and report of a case. Cancer 1971; 27:823-830.
37. Rieker RJ, Hoegel J, Morresi-Hauf A, et al. Histologic classification of thymic epithelial tumors: comparison of established classification schemes. Int J Cancer 2002;98:900-906.
38. Chen G, Marx A, Wen-Hu C, et al. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer 2002;95:420-429.
39. Lardinois D, Rechsteiner R, Lang RH, et al. Prognostic relevance of Masaoka and Muller-Hermelink classification in patients with thymic tumors. Ann Thorac Surg 2000;69:1550-1555.
40. Kim DJ, Yang WI, Choi SS, et al. Prognostic and clinical relevance of the World Health Organization schema for the classification of thymic epithelial tumors: a clinicopathologic study of 108 patients and literature review. Chest 2005;127:755-761.
41. Mineo TC, Ambrogi V, Mineo D, et al. Long-term disease-free survival of patients with radically resected thymomas: relevance of cell-cycle protein expression. Cancer 2005;104:2063-2071.
42. Okumura M, Miyoshi S, Fujii Y, et al. Clinical and functional significance of WHO classification on human thymic epithelial neoplasms: a study of 146 consecutive tumors. Am J Surg Pathol 2001;25: 103-110.
43. Okumura M, Shiono H, Inoue M, et al. Outcome of surgical treatment for recurrent thymic epithelial tumors with reference to world health organization histologic classification system. J Surg Oncol 2007; 95:40-44.
44. Park MS, Chung KY, Kim KD, et al. Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification. Ann Thorac Surg 2004;78:992-997, discussion 7-8.
45. Rea F, Marulli G, Girardi R, et al. Long-term survival and prognostic factors in thymic epithelial tumours. Eur J Cardiothorac Surg 2004;26:412-418.
46. Marchevsky AM, Gupta R, McKenna RJ, et al. Evidence-based pathology and the pathologic evaluation of thymomas: the World Health Organization classification can be simplified into only 3 categories other than thymic carcinoma. Cancer 2008;112: 2780-2788.
47. Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 2003;76:878-884, discussion 84-5.
48. Nakagawa K, Asamura H, Matsuno Y, et al. Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorac Cardio-vasc Surg 2003;126:1134-1140.
49. Kuo TT, Chan JK. Thymic carcinoma arising in thymoma is associated with alterations in immuno-histochemical profile. Am J Surg Pathol 1998;22: 1474-1481.
50. Suster S, Moran CA. Spindle cell thymic carcinoma: clinicopathologic and immunohistochemical study of a distinctive variant of primary thymic epithelial neoplasm. Am J Surg Pathol 1999;23:691-700.
51. Maggi G, Casadio C, Cavallo A, et al. Thymoma: results of 241 operated cases. Ann Thorac Surg 1991; 51:152-156.
52. Pescarmona E, Rendina EA, Venuta F, et al. Analysis of prognostic factors and clinicopathological staging of thymoma. Ann Thorac Surg 1990;50: 534-538.
53. Quintanilla-Martinez L, Wilkins Jr EW, Choi N, et al. Thymoma. Histologic subclassification is an independent prognostic factor. Cancer 1994;74:606-617.
54. Suster S, Moran CA. Thymoma, atypical thymoma, and thymic carcinoma. A novel conceptual approach to the classification of thymic epithelial neoplasms. Am J Clin Pathol 1999;111:826-833.